Literature DB >> 24126976

The role of Chinese medicine in clinical oncology.

Yan Sun1.   

Abstract

Chinese Medicine (CM) has been used for several thousand years, playing an important role in the prevention and treatment of diseases including cancer. In the recent four decades, a number of CM herbs have aroused extreme interest in the world-isolating anticancer components from medicinal herbs, using them as biological response modifiers, and most recently as angiogenesis inhibitors. The present review reports both the experimental and clinical results obtained in the field of clinical oncology, especially conducted by our group. The review also presents the possible future of integration of CM and modern medicine in basic research and clinical practice, especially when CM used as adjuvant and maintenance therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24126976     DOI: 10.1007/s11655-013-1551-2

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  15 in total

1.  [Kanglaite for Treating Advanced Non-small-cell Lung Cancer: A Systematic Review.].

Authors:  Lina Zhu; Zhenjun Yang; Shiyong Wang; Yanming Tang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2009-03-20

2.  Two hundred years of cancer research.

Authors:  Vincent T DeVita; Steven A Rosenberg
Journal:  N Engl J Med       Date:  2012-05-30       Impact factor: 91.245

Review 3.  Could we use clinical benefit to evaluate the effects of chinese medicine on the treatment of cancer?

Authors:  Ping-ping Li
Journal:  Chin J Integr Med       Date:  2010-02-04       Impact factor: 1.978

4.  Effect of Radix Astragali seu Hedysari on the interferon system.

Authors:  Y D Hou; G L Ma; S H Wu; Y Y Li; H T Li
Journal:  Chin Med J (Engl)       Date:  1981-01       Impact factor: 2.628

5.  Immune restoration and/or augmentation of local graft versus host reaction by traditional Chinese medicinal herbs.

Authors:  Y Sun; E M Hersh; M Talpaz; S L Lee; W Wong; T L Loo; G M Mavligit
Journal:  Cancer       Date:  1983-07-01       Impact factor: 6.860

6.  [Pharmacokinetic studies of 20(R)-ginsenoside RG3 in human volunteers].

Authors:  H Pang; H L Wang; L Fu; C Y Su
Journal:  Yao Xue Xue Bao       Date:  2001-03

7.  Fractionated extract of Astragalus membranaceus, a Chinese medicinal herb, potentiates LAK cell cytotoxicity generated by a low dose of recombinant interleukin-2.

Authors:  D T Chu; J Lepe-Zuniga; W L Wong; R LaPushin; G M Mavligit
Journal:  J Clin Lab Immunol       Date:  1988-08

8.  Preliminary observations on the effects of the Chinese medicinal herbs Astragalus membranaceus and Ligustrum lucidum on lymphocyte blastogenic responses.

Authors:  Y Sun; E M Hersh; S L Lee; M McLaughlin; T L Loo; G M Mavligit
Journal:  J Biol Response Mod       Date:  1983

9.  Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells.

Authors:  Takayuki Ikezoe; Sophie S Chen; Xian-Jun Tong; David Heber; Hirokuni Taguchi; H Phillip Koeffler
Journal:  Int J Oncol       Date:  2003-10       Impact factor: 5.650

10.  [Efficacy of Shenyi Capsule combined with gemcitabine plus cisplatin in treatment of advanced esophageal cancer: a randomized controlled trial].

Authors:  Jing-yu Huang; Yan Sun; Qing-xia Fan; Yu-qing Zhang
Journal:  Zhong Xi Yi Jie He Xue Bao       Date:  2009-11
View more
  8 in total

1.  Dampness-Heat Accelerates DMBA-Induced Mammary Tumors in Rats.

Authors:  Wei Dong; Xi-Lan Tang; Guang-Bin Shang; Guo-Liang Xu; Wei-Feng Zhu; Hong-Ning Liu
Journal:  Chin J Integr Med       Date:  2017-09-15       Impact factor: 1.978

2.  Oridonin induces autophagy-mediated cell death in pancreatic cancer by activating the c-Jun N-terminal kinase pathway and inhibiting phosphoinositide 3-kinase signaling.

Authors:  Xin Zhao; Qi Zhang; Yuanyuan Wang; Shipeng Li; Xiangyang Yu; Botao Wang; Ximo Wang
Journal:  Ann Transl Med       Date:  2021-07

3.  An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis.

Authors:  Rui Liu; Shu-Lin He; Yoshiro Hirasaki; Hong-Gang Zheng; Bao-Jin Hua
Journal:  Chin J Integr Med       Date:  2015-11-23       Impact factor: 1.978

Review 4.  Chinese Herbal Medicines as an Adjunctive Therapy for Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Authors:  Bin Li; Run Gan; Quanjun Yang; Jinlu Huang; Pengguo Chen; Lili Wan; Cheng Guo
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-23       Impact factor: 2.629

5.  Marsdenia tenacissima extract suppresses tumor growth and angiogenesis in A20 mouse lymphoma.

Authors:  Xingbin Dai; Yanhua Ji; Pengjun Jiang; Xuemei Sun
Journal:  Oncol Lett       Date:  2017-03-08       Impact factor: 2.967

6.  In vitro and in vivo effects of traditional Chinese medicine formula T33 in human breast cancer cells.

Authors:  Yu-Te Liu; Chao-Hsiang Hsiao; Bor-Show Tzang; Tsai-Ching Hsu
Journal:  BMC Complement Altern Med       Date:  2019-08-13       Impact factor: 3.659

7.  Hyperoside Induces Breast Cancer Cells Apoptosis via ROS-Mediated NF-κB Signaling Pathway.

Authors:  Jinxia Qiu; Tao Zhang; Xinying Zhu; Chao Yang; Yaxing Wang; Ning Zhou; Bingxin Ju; Tianhong Zhou; Ganzhen Deng; Changwei Qiu
Journal:  Int J Mol Sci       Date:  2019-12-24       Impact factor: 5.923

8.  Yangzheng Sanjie decoction regulates proliferation and apoptosis of gastric cancer cells by enhancing let-7a expression.

Authors:  Hai-Xia Deng; Ya-Ya Yu; Ao-Qiang Zhou; Jing-Li Zhu; Li-Na Luo; Wan-Qun Chen; Ling Hu; Geng-Xin Chen
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.